Q: What was the study design?

Retrospective, non-randomized before-and-after cohort study with chronological (historical) allocation, n=58 (36 earlier conventional cohort, 22 later preservation cohort) from a single center undergoing primary ACLR; this sits low on the evidence hierarchy, below any prospective comparative study.

Q: How trustworthy is the methodology?

Because the two groups were defined by time period rather than randomization, any temporal co-intervention (surgeon experience, rehab protocol changes, implant or technique drift over the 2021-2024 window) is fully confounded with 'treatment group', and the authors themselves flag this as an associative design needing prospective confirmation. Group sizes are small and unequal (36 vs 22), raising power concerns for the non-significant IKDC and 6-month comparisons, and MRI fibrosis grading, scored presumably by non-blinded readers given the retrospective design, is a surrogate rather than a validated patient-centered endpoint. No mention of blinded outcome assessment, sample size calculation, or adjustment for confounders (age, graft type, concomitant procedures) was given in the abstract, and single-center retrospective series are prone to selection and performance bias.

Q: What is the overall appraisal?

The fibrosis reduction (RR 0.22) is a large relative effect but it's a surrogate imaging outcome whose link to long-term knee function is unproven, and the early pain/function differences (VAS 1.3 points, Kujala ~10 points) are plausibly clinically relevant if real, but the chronological allocation means these could just as easily reflect a learning curve, evolving rehab protocols, or other unmeasured secular trends rather than the suture technique itself. The groups are also small and unequal (36 vs 22), several outcomes were tested without any stated correction for multiplicity, and the paper doesn't say whether the 6-month MRI fibrosis grading was done blind to group allocation, which matters a lot for a surgeon-championed imaging outcome. By 6 months the functional advantage had washed out (Lysholm, ROM similar), undercutting the durability of the clinical benefit even if the imaging difference persists.

Q: What is the main limitation?

A prospective, ideally randomized, trial with blinded MRI grading and a larger, balanced sample is needed before concluding the suture retraction technique itself, rather than secular changes in surgical or rehab practice, drives the outcome differences.

Q: What should clinicians do on Monday?

Not yet actionable for most surgeons on Monday: it's a reasonable, low-risk technical idea (suture retraction instead of resection) worth discussing with arthroscopic colleagues, but the retrospective, confounded design means it shouldn't be adopted as a standard-of-care change on this evidence alone.

Q: How do I apply this in practice?

This doesn't change anything for either clinic or gym floor on Monday: the functional gap closed by 6 months and the design can't separate the suture technique from secular changes in surgical or rehab practice over the 3-year window. For physios managing early post-ACLR patients, the practical takeaway is to keep assessing anterior knee pain and extension loss on their own merits rather than attributing slower early recovery to 'bad technique' if you don't know what the surgeon did; standard early ROM and pain management stays the same. For S&C, RTS criteria (quad strength symmetry, hop testing) and loading progression after ACLR shouldn't move based on this study, since by 6 months outcomes converged regardless of fat pad handling. The one thing worth flagging to surgical colleagues is that fat-pad resection may be worth revisiting as a default habit, but that's a conversation to have, not a protocol to change, until this is tested prospectively.

Question 1

What did the study find?

Accepted Answer

The IPFP-preservation group had better 3-month Kujala (90.5 vs 80.7, P=.013), VAS (0.9 vs 2.2, P<.001), and Lysholm scores (89.2 vs 76.9, P=.003), and much less moderate-to-severe fat pad fibrosis at 6 months (18.2% vs 83.3%, RR 0.22, 95% CI 0.09-0.54); IKDC and 6-month Lysholm/ROM did not differ.

Question 2

What was the study design?

Accepted Answer

Retrospective, non-randomized before-and-after cohort study with chronological (historical) allocation, n=58 (36 earlier conventional cohort, 22 later preservation cohort) from a single center undergoing primary ACLR; this sits low on the evidence hierarchy, below any prospective comparative study.

Question 3

How trustworthy is the methodology?

Accepted Answer

Because the two groups were defined by time period rather than randomization, any temporal co-intervention (surgeon experience, rehab protocol changes, implant or technique drift over the 2021-2024 window) is fully confounded with 'treatment group', and the authors themselves flag this as an associative design needing prospective confirmation. Group sizes are small and unequal (36 vs 22), raising power concerns for the non-significant IKDC and 6-month comparisons, and MRI fibrosis grading, scored presumably by non-blinded readers given the retrospective design, is a surrogate rather than a validated patient-centered endpoint. No mention of blinded outcome assessment, sample size calculation, or adjustment for confounders (age, graft type, concomitant procedures) was given in the abstract, and single-center retrospective series are prone to selection and performance bias.

Question 4

What is the overall appraisal?

Accepted Answer

The fibrosis reduction (RR 0.22) is a large relative effect but it's a surrogate imaging outcome whose link to long-term knee function is unproven, and the early pain/function differences (VAS 1.3 points, Kujala ~10 points) are plausibly clinically relevant if real, but the chronological allocation means these could just as easily reflect a learning curve, evolving rehab protocols, or other unmeasured secular trends rather than the suture technique itself. The groups are also small and unequal (36 vs 22), several outcomes were tested without any stated correction for multiplicity, and the paper doesn't say whether the 6-month MRI fibrosis grading was done blind to group allocation, which matters a lot for a surgeon-championed imaging outcome. By 6 months the functional advantage had washed out (Lysholm, ROM similar), undercutting the durability of the clinical benefit even if the imaging difference persists.

Question 5

What is the main limitation?

Accepted Answer

A prospective, ideally randomized, trial with blinded MRI grading and a larger, balanced sample is needed before concluding the suture retraction technique itself, rather than secular changes in surgical or rehab practice, drives the outcome differences.

Question 6

What should clinicians do on Monday?

Accepted Answer

Not yet actionable for most surgeons on Monday: it's a reasonable, low-risk technical idea (suture retraction instead of resection) worth discussing with arthroscopic colleagues, but the retrospective, confounded design means it shouldn't be adopted as a standard-of-care change on this evidence alone.

Question 7

How do I apply this in practice?

Accepted Answer

This doesn't change anything for either clinic or gym floor on Monday: the functional gap closed by 6 months and the design can't separate the suture technique from secular changes in surgical or rehab practice over the 3-year window. For physios managing early post-ACLR patients, the practical takeaway is to keep assessing anterior knee pain and extension loss on their own merits rather than attributing slower early recovery to 'bad technique' if you don't know what the surgeon did; standard early ROM and pain management stays the same. For S&C, RTS criteria (quad strength symmetry, hop testing) and loading progression after ACLR shouldn't move based on this study, since by 6 months outcomes converged regardless of fat pad handling. The one thing worth flagging to surgical colleagues is that fat-pad resection may be worth revisiting as a default habit, but that's a conversation to have, not a protocol to change, until this is tested prospectively.

Suture Retraction to Preserve the Infrapatellar Fat Pad During Anterior Cruciate Ligament Reconstruction: A Retrospective Cohort Study

The paper

What they found

Study design

Methodology

The appraisal

The gap

Landmark context

What to do Monday

In practice

The five papers that matter — every week, free.

Related appraisals